BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

902 related articles for article (PubMed ID: 17117433)

  • 1. Screening for depression and anxiety disorders in primary care patients.
    Bunevicius A; Peceliuniene J; Mickuviene N; Valius L; Bunevicius R
    Depress Anxiety; 2007; 24(7):455-60. PubMed ID: 17117433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening for anxiety and depression after stroke: comparison of the hospital anxiety and depression scale and the Montgomery and Asberg depression rating scale.
    Sagen U; Vik TG; Moum T; Mørland T; Finset A; Dammen T
    J Psychosom Res; 2009 Oct; 67(4):325-32. PubMed ID: 19773025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychiatric morbidity and its screening in Turkish women with breast cancer: a comparison between the HADS and SCID tests.
    Ozalp E; Soygür H; Cankurtaran E; Turhan L; Akbiyik D; Geyik P
    Psychooncology; 2008 Jul; 17(7):668-75. PubMed ID: 17992701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive and anxiety symptoms in screening for clinical depression in diabetes: a systematic examination of diagnostic performances of the HADS and BDI-SF.
    Sultan S; Luminet O; Hartemann A
    J Affect Disord; 2010 Jun; 123(1-3):332-6. PubMed ID: 19861228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationships among pain, anxiety, and depression in primary care.
    Means-Christensen AJ; Roy-Byrne PP; Sherbourne CD; Craske MG; Stein MB
    Depress Anxiety; 2008; 25(7):593-600. PubMed ID: 17932958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Examination of the known-groups validity of the Liebowitz Social Anxiety Scale.
    Heimberg RG; Holaway RM
    Depress Anxiety; 2007; 24(7):447-54. PubMed ID: 17120297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The accuracy of HADS and GHQ-12 in detecting psychiatric morbidity in breast cancer patients].
    Krespi Boothby MR; Hill J; Holcombe C; Clark L; Fisher J; Salmon P
    Turk Psikiyatri Derg; 2010; 21(1):49-59. PubMed ID: 20204904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rasch analysis of the scoring scheme of the HADS Depression subscale in Chinese stroke patients.
    Tang WK; Wong E; Chiu HF; Ungvari GS
    Psychiatry Res; 2007 Feb; 150(1):97-103. PubMed ID: 17267049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validity of the patient health questionnaire (PHQ-9) as a screening tool for depression amongst Nigerian university students.
    Adewuya AO; Ola BA; Afolabi OO
    J Affect Disord; 2006 Nov; 96(1-2):89-93. PubMed ID: 16857265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance of the Hospital Anxiety and Depression Scale as a screening tool for major depressive disorder in cancer patients.
    Walker J; Postma K; McHugh GS; Rush R; Coyle B; Strong V; Sharpe M
    J Psychosom Res; 2007 Jul; 63(1):83-91. PubMed ID: 17586341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distress and its correlates in Korean cancer patients: pilot use of the distress thermometer and the problem list.
    Shim EJ; Shin YW; Jeon HJ; Hahm BJ
    Psychooncology; 2008 Jun; 17(6):548-55. PubMed ID: 17957764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening capacity of the Multidimensional Anxiety Scale for Children (MASC) for DSM-IV anxiety disorders.
    van Gastel W; Ferdinand RF
    Depress Anxiety; 2008; 25(12):1046-52. PubMed ID: 18833579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prevalence of depressive disorders in children and adolescents attending primary care. A survey with the Aquitaine Sentinelle Network].
    Mathet F; Martin-Guehl C; Maurice-Tison S; Bouvard MP
    Encephale; 2003; 29(5):391-400. PubMed ID: 14615688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validity of the Hospital Anxiety and Depression Scale to assess depression and anxiety following traumatic brain injury as compared with the Structured Clinical Interview for DSM-IV.
    Whelan-Goodinson R; Ponsford J; Schönberger M
    J Affect Disord; 2009 Apr; 114(1-3):94-102. PubMed ID: 18656266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of the Hospital Anxiety and Depression Scale for use with multiple sclerosis patients.
    Honarmand K; Feinstein A
    Mult Scler; 2009 Dec; 15(12):1518-24. PubMed ID: 19965520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reliability and validity of the Hospital Anxiety and Depression Scale and the Beck Depression Inventory (Full and FastScreen scales) in detecting depression in persons with hepatitis C.
    Golden J; Conroy RM; O'Dwyer AM
    J Affect Disord; 2007 Jun; 100(1-3):265-9. PubMed ID: 17156850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validity and reliability of the Hospital Anxiety and Depression Scale in a hypertrophic cardiomyopathy clinic: the HADS in a cardiomyopathy population.
    Poole NA; Morgan JF
    Gen Hosp Psychiatry; 2006; 28(1):55-8. PubMed ID: 16377366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The structure and dimensionality of the Inventory of Depressive Symptomatology Self Report (IDS-SR) in patients with depressive disorders and healthy controls.
    Wardenaar KJ; van Veen T; Giltay EJ; den Hollander-Gijsman M; Penninx BW; Zitman FG
    J Affect Disord; 2010 Sep; 125(1-3):146-54. PubMed ID: 20074811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening for anxiety and depression in primary care with the Duke Anxiety-Depression Scale.
    Parkerson GR; Broadhead WE
    Fam Med; 1997 Mar; 29(3):177-81. PubMed ID: 9085098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The HADS and the DT for screening psychosocial distress of cancer patients in Taiwan.
    Wang GL; Hsu SH; Feng AC; Chiu CY; Shen JF; Lin YJ; Cheng CC
    Psychooncology; 2011 Jun; 20(6):639-46. PubMed ID: 21626611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.